Dana-Farber Cancer Institute

This is your central portal for breaking news, the latest research and important updates from Dana-Farber Cancer Institute. Bookmark this page and check back often for updates.

Meeting News

HER-2 mutations linked to hormone therapy resistance in breast cancer subtype

March 16, 2018
HER-2 mutations appeared associated with resistance to hormone therapy among women with ER-positive metastatic breast cancer, according to a study…

Many questions remain about link between sugar intake and cancer

March 2, 2018
Elevated levels of blood glucose are linked to an increased risk for a number of cancers, including breast and colorectal cancers. Blood glucose…

Stand Up To Cancer dream team strives for ‘active interception’ of pancreatic cancer

March 1, 2018
The Stand Up To Cancer foundation has formed a “dream team” to identify new ways to detect pancreatic cancer at earlier stages when it is…

Does WBRT still have a role for limited brain metastases?

HemOnc Today, February 10, 2018
POINT The Choosing Wisely recommendation from the American Society for Radiation Oncology (ASTRO) states to not “routinely add adjuvant WBRT to…

HemOnc Today honors inaugural Next Gen Innovators

HemOnc Today, January 10, 2018
HemOnc Today honored its inaugural class of Next Gen Innovators during the ASH Annual Meeting and Exposition. The Next Gen Innovators are a highly…

Better strategies needed to tailor surveillance mammography for older breast cancer survivors

December 27, 2017
More than half of older breast cancer survivors with an estimated life expectancy of less than 5 years reported undergoing a surveillance mammogram…
Meeting NewsPerspective

BLU-285 induces rapid responses in advanced systemic mastocytosis

December 11, 2017
ATLANTA — BLU-285 appeared active and safe among patients with advanced systemic mastocytosis, according to phase 1 data presented during the…
Meeting NewsPerspective

Lymph node surgery increases arm morbidity in younger women with breast cancer

December 8, 2017
SAN ANTONIO — Younger women who underwent axillary surgery for breast cancer appeared more likely to experience
Meeting News

Dual HER-2 therapy with trastuzumab, lapatinib improves EFS

December 7, 2017
SAN ANTONIO — The addition of lapatinib to trastuzumab with taxane therapy improved EFS among a cohort of patients with HER-2-positive breast…
In the Journals Plus

Savolitinib shows some activity for papillary renal cell carcinoma

November 28, 2017
Savolitinib monotherapy demonstrated antitumor activity and appeared tolerable among patients with advanced papillary renal cell carcinoma, according…

Multinational study to compare three regimens for first-line treatment of advanced renal cell carcinoma

November 22, 2017
A multinational study is underway to compare three treatment strategies for patients with previously untreated advanced or metastatic kidney cancer…
Meeting NewsVideo

VIDEO: Symposium offers research, mentorship opportunities

November 3, 2017
MIAMI Toni K. Choueiri, MD, from Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, interviews two members of the Scientific…
Meeting NewsVideo

VIDEO: Geographic location plays role in renal cell carcinoma outcomes

November 3, 2017
MIAMI Toni K. Choueiri, MD, from Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, discusses how treatment center location may…
Meeting News

Secondary data analysis offers ‘high-impact’ approach to improving patient care

November 3, 2017
MIAMI Secondary data analysis enables researchers to provide high-impact data; however, implementation of this approach can be complex, Maxine Sun

Three clinicians elected to ASH executive committee

November 1, 2017
ASH today announced the election of three new members to its executive committee. Stephanie Lee, MD — member of Fred Hutchinson Cancer…

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer…

Hematologists, oncologists elected to National Academy of Medicine

October 16, 2017
The National Academy of Medicine today announced the election of 70 regular members and 10 international members. Election to the academy —…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of…
Meeting News

Cabozantinib extends PFS as first-line therapy for metastatic renal cell carcinoma

September 11, 2017
MADRID — Cabozantinib significantly extended PFS compared with sunitinib as initial targeted therapy for patients with metastatic renal cell…
FDA NewsPerspective

FDA approves Kymriah as first chimeric antigen receptor T-cell therapy

August 30, 2017
The FDA approved tisagenlecleucel T-suspension for the treatment of children and young adults with B-cell acute lymphoblastic leukemia…